Psychedelic Research

Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K., Woolley, J. D., & Davoli, C. C. (2024). Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study. Journal of Psychoactive Drugs, 1-10. https://doi.org/10.1080/02791072.2024.2312980

Bonnelle, V., Feilding, A., Rosas, F. E., Nutt, D. J., Carhart-Harris, R. L., & Timmermann, C. (2024). Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing. bioRxiv, 2024-03. https://doi.org/10.1101/2024.03.19.585567

Davis, A. K., Xin, Y., Sepeda, N., & Averill, L. A. (2023). Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico. The American Journal of Drug and Alcohol Abuse, 49(5), 587-596. https://doi.org/10.1080/00952990.2023.2220874

Greenstein, K. (2024). Why does it (still) feel like a lot of people don’t really care about addressing the problem of exploitative and abusive therapists in psychedelic therapy? Medium. https://medium.com/@kgreenstien/why-does-it-still-feel-like-a-lot-of-people-dont-really-care-about-addressing-the-problem-of-e48d30030742

Gründer, G., Brand, M., Mertens, L. J., Jungaberle, H., Kärtner, L., Scharf, D. J., ... & Wolff, M. (2024). Treatment with psychedelics is psychotherapy: Beyond reductionism. The Lancet Psychiatry, 11(3), 231-236. https://doi.org/10.1016/S2215-0366(23)00363-2

Hausfeld, R. (2024). Building Better Killing Machines — With Ecstasy!: Rick Doblin, the pioneer of MDMA therapy, advocates for dosing soldiers upon enlistment. Truthdig. https://www.truthdig.com/articles/building-better-killing-machines-with-ecstasy/

Koenigshofer, Kenneth. Between-Neuron Communication- Synaptic Transmission https://socialsci.libretexts.org/Courses/Sacramento_City_College/Psyc_310%3A_Biological_Psychology_(Keys)/05%3A_Communication_within_the_Nervous_System/5.03%3A_Between-Neuron_Communicaton-_Synaptic_Transmission

Kuntz, L. (2024). FDA Grants Breakthrough Designation to MM-120 for Generalized Anxiety Disorder. Psychiatric Times. https://www.psychiatrictimes.com/view/fda-grants-breakthrough-designation-to-mm-120-for-generalized-anxiety-disorder

Lear, M. K., Smith, S. M., Pilecki, B., Stauffer, C. S., & Luoma, J. B. (2023). Social anxiety and MDMA-assisted therapy investigation: A novel clinical trial protocol. Frontiers in Psychiatry, 14, 1083354. https://doi.org/10.3389/fpsyt.2023.1083354

Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., ... & Davis, A. K. (2024). The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. PloS one, 19(3), e0300501. https://doi.org/10.1371/journal.pone.0300501

Luoma, J. B., Shahar, B., Kati Lear, M., Pilecki, B., & Wagner, A. (2022). Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships. Human Psychopharmacology: Clinical and Experimental, 37(3), e2824. https://doi.org/10.1002/hup.2824

Luoma, J., Allen, L. R., Gold, V., & Stauffer, C. (2024). Getting in Touch with Touch: The Importance of Studying Touch in Mdma-assisted Therapy and the Development of a New Self-report Measure. Psychedelic Medicine. https://doi.org/10.1089/psymed.2023.0033

Lyu, J., Kapolka, N., Gumpper, R., Alon, A., Wang, L., Jain, M. K., ... & Roth, B. L. (2023). AlphaFold2 structures template ligand discovery. bioRxiv, 2023-12. https://doi.org/10.1101/2023.12.20.572662

Simonsson, O., Mosing, M. A., Osika, W., Ullén, F., Larsson, H., Lu, Y., & Wesseldijk, L. W. (2024). Adolescent psychedelic use and psychotic or manic symptoms. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2024.0047

Simonsson, O., Osika, W., Stenfors, C. U., Goldberg, S. B., Honk, L., & Hendricks, P. S. (2024). Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom. Psychological Medicine, 54(6), 1228-1234. https://doi.org/10.1017/S0033291723003082

Sloshower, J., Zeifman, R. J., Guss, J., Krause, R., Safi-Aghdam, H., Pathania, S., ... & D’Souza, D. C. (2024). Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial. Scientific Reports, 14(1), 8833. https://doi.org/10.1038/s41598-024-58318-x

Zeifman, R. J., Wagner, A. C., Monson, C. M., & Carhart-Harris, R. L. (2023). How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change. Journal of Affective Disorders, 334, 100-112. https://doi.org/10.1016/j.jad.2023.04.105